256 related articles for article (PubMed ID: 28436985)
1. Functional screen of MSI2 interactors identifies an essential role for SYNCRIP in myeloid leukemia stem cells.
Vu LP; Prieto C; Amin EM; Chhangawala S; Krivtsov A; Calvo-Vidal MN; Chou T; Chow A; Minuesa G; Park SM; Barlowe TS; Taggart J; Tivnan P; Deering RP; Chu LP; Kwon JA; Meydan C; Perales-Paton J; Arshi A; Gönen M; Famulare C; Patel M; Paietta E; Tallman MS; Lu Y; Glass J; Garret-Bakelman FE; Melnick A; Levine R; Al-Shahrour F; Järås M; Hacohen N; Hwang A; Garippa R; Lengner CJ; Armstrong SA; Cerchietti L; Cowley GS; Root D; Doench J; Leslie C; Ebert BL; Kharas MG
Nat Genet; 2017 Jun; 49(6):866-875. PubMed ID: 28436985
[TBL] [Abstract][Full Text] [Related]
2. Musashi2 sustains the mixed-lineage leukemia-driven stem cell regulatory program.
Park SM; Gönen M; Vu L; Minuesa G; Tivnan P; Barlowe TS; Taggart J; Lu Y; Deering RP; Hacohen N; Figueroa ME; Paietta E; Fernandez HF; Tallman MS; Melnick A; Levine R; Leslie C; Lengner CJ; Kharas MG
J Clin Invest; 2015 Mar; 125(3):1286-98. PubMed ID: 25664853
[TBL] [Abstract][Full Text] [Related]
3. RNA binding protein SYNCRIP maintains proteostasis and self-renewal of hematopoietic stem and progenitor cells.
Herrejon Chavez F; Luo H; Cifani P; Pine A; Chu KL; Joshi S; Barin E; Schurer A; Chan M; Chang K; Han GYQ; Pierson AJ; Xiao M; Yang X; Kuehm LM; Hong Y; Nguyen DTT; Chiosis G; Kentsis A; Leslie C; Vu LP; Kharas MG
Nat Commun; 2023 Apr; 14(1):2290. PubMed ID: 37085479
[TBL] [Abstract][Full Text] [Related]
4. Cooperation between AlphavBeta3 integrin and the fibroblast growth factor receptor enhances proliferation of Hox-overexpressing acute myeloid leukemia cells.
Shah CA; Bei L; Wang H; Altman JK; Platanias LC; Eklund EA
Oncotarget; 2016 Aug; 7(34):54782-54794. PubMed ID: 27340869
[TBL] [Abstract][Full Text] [Related]
5. Musashi 2 influences chronic lymphocytic leukemia cell survival and growth making it a potential therapeutic target.
Palacios F; Yan XJ; Ferrer G; Chen SS; Vergani S; Yang X; Gardner J; Barrientos JC; Rock P; Burack R; Kolitz JE; Allen SL; Kharas MG; Abdel-Wahab O; Rai KR; Chiorazzi N
Leukemia; 2021 Apr; 35(4):1037-1052. PubMed ID: 33504942
[TBL] [Abstract][Full Text] [Related]
6. Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia.
Kharas MG; Lengner CJ; Al-Shahrour F; Bullinger L; Ball B; Zaidi S; Morgan K; Tam W; Paktinat M; Okabe R; Gozo M; Einhorn W; Lane SW; Scholl C; Fröhling S; Fleming M; Ebert BL; Gilliland DG; Jaenisch R; Daley GQ
Nat Med; 2010 Aug; 16(8):903-8. PubMed ID: 20616797
[TBL] [Abstract][Full Text] [Related]
7. The PAF1c Subunit CDC73 Is Required for Mouse Hematopoietic Stem Cell Maintenance but Displays Leukemia-Specific Gene Regulation.
Saha N; Ropa J; Chen L; Hu H; Mysliwski M; Friedman A; Maillard I; Muntean AG
Stem Cell Reports; 2019 May; 12(5):1069-1083. PubMed ID: 31031188
[TBL] [Abstract][Full Text] [Related]
8. HyperTRIBE uncovers increased MUSASHI-2 RNA binding activity and differential regulation in leukemic stem cells.
Nguyen DTT; Lu Y; Chu KL; Yang X; Park SM; Choo ZN; Chin CR; Prieto C; Schurer A; Barin E; Savino AM; Gourkanti S; Patel P; Vu LP; Leslie CS; Kharas MG
Nat Commun; 2020 Apr; 11(1):2026. PubMed ID: 32332729
[TBL] [Abstract][Full Text] [Related]
9. MSI2 is required for maintaining activated myelodysplastic syndrome stem cells.
Taggart J; Ho TC; Amin E; Xu H; Barlowe TS; Perez AR; Durham BH; Tivnan P; Okabe R; Chow A; Vu L; Park SM; Prieto C; Famulare C; Patel M; Lengner CJ; Verma A; Roboz G; Guzman M; Klimek VM; Abdel-Wahab O; Leslie C; Nimer SD; Kharas MG
Nat Commun; 2016 Feb; 7():10739. PubMed ID: 26898884
[TBL] [Abstract][Full Text] [Related]
10. A novel miR-375-HOXB3-CDCA3/DNMT3B regulatory circuitry contributes to leukemogenesis in acute myeloid leukemia.
Bi L; Zhou B; Li H; He L; Wang C; Wang Z; Zhu L; Chen M; Gao S
BMC Cancer; 2018 Feb; 18(1):182. PubMed ID: 29439669
[TBL] [Abstract][Full Text] [Related]
11. Musashi-2 Silencing Exerts Potent Activity against Acute Myeloid Leukemia and Enhances Chemosensitivity to Daunorubicin.
Han Y; Ye A; Zhang Y; Cai Z; Wang W; Sun L; Jiang S; Wu J; Yu K; Zhang S
PLoS One; 2015; 10(8):e0136484. PubMed ID: 26308531
[TBL] [Abstract][Full Text] [Related]
12. Roles for MSI2 and PROX1 in hematopoietic stem cell activity.
Hope KJ; Sauvageau G
Curr Opin Hematol; 2011 Jul; 18(4):203-7. PubMed ID: 21577104
[TBL] [Abstract][Full Text] [Related]
13. Small-molecule targeting of MUSASHI RNA-binding activity in acute myeloid leukemia.
Minuesa G; Albanese SK; Xie W; Kazansky Y; Worroll D; Chow A; Schurer A; Park SM; Rotsides CZ; Taggart J; Rizzi A; Naden LN; Chou T; Gourkanti S; Cappel D; Passarelli MC; Fairchild L; Adura C; Glickman JF; Schulman J; Famulare C; Patel M; Eibl JK; Ross GM; Bhattacharya S; Tan DS; Leslie CS; Beuming T; Patel DJ; Goldgur Y; Chodera JD; Kharas MG
Nat Commun; 2019 Jun; 10(1):2691. PubMed ID: 31217428
[TBL] [Abstract][Full Text] [Related]
14. SYNCRIP, a new player in pri-let-7a processing.
Chen Y; Chan J; Chen W; Li J; Sun M; Kannan GS; Mok YK; Yuan YA; Jobichen C
RNA; 2020 Mar; 26(3):290-305. PubMed ID: 31907208
[TBL] [Abstract][Full Text] [Related]
15. Musashi 2 in hematopoiesis.
de Andrés-Aguayo L; Varas F; Graf T
Curr Opin Hematol; 2012 Jul; 19(4):268-72. PubMed ID: 22517588
[TBL] [Abstract][Full Text] [Related]
16. RNA-binding proteins as drivers of AML and novel therapeutic targets.
Qin T; Cheng Y; Wang X
Leuk Lymphoma; 2022 May; 63(5):1045-1057. PubMed ID: 35075986
[TBL] [Abstract][Full Text] [Related]
17. Musashi2 modulates K562 leukemic cell proliferation and apoptosis involving the MAPK pathway.
Zhang H; Tan S; Wang J; Chen S; Quan J; Xian J; Zhang Ss; He J; Zhang L
Exp Cell Res; 2014 Jan; 320(1):119-27. PubMed ID: 24076374
[TBL] [Abstract][Full Text] [Related]
18. Regulation of HOXA9 activity by predominant expression of DACH1 against C/EBPα and GATA-1 in myeloid leukemia with MLL-AF9.
Lee JW; Kim HS; Hwang J; Kim YH; Lim GY; Sohn WJ; Yoon SR; Kim JY; Park TS; Oh SH; Park KM; Choi SU; Ryoo ZY; Lee S
Biochem Biophys Res Commun; 2012 Sep; 426(3):299-305. PubMed ID: 22902925
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of miR-128a induces Lin28a expression and reverts myeloid differentiation blockage in acute myeloid leukemia.
De Luca L; Trino S; Laurenzana I; Tagliaferri D; Falco G; Grieco V; Bianchino G; Nozza F; Campia V; D'Alessio F; La Rocca F; Caivano A; Villani O; Cilloni D; Musto P; Del Vecchio L
Cell Death Dis; 2017 Jun; 8(6):e2849. PubMed ID: 28569789
[TBL] [Abstract][Full Text] [Related]
20. CARM1 Is Essential for Myeloid Leukemogenesis but Dispensable for Normal Hematopoiesis.
Greenblatt SM; Man N; Hamard PJ; Asai T; Karl D; Martinez C; Bilbao D; Stathias V; Jermakowicz AM; Duffort S; Tadi M; Blumenthal E; Newman S; Vu L; Xu Y; Liu F; Schurer SC; McCabe MT; Kruger RG; Xu M; Yang FC; Tenen DG; Watts J; Vega F; Nimer SD
Cancer Cell; 2018 Jun; 33(6):1111-1127.e5. PubMed ID: 29894694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
